Ritchie Lab - Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention.

Bergmeijer, T., Yasmina, A., Vos, G., Janssen, P., Hackeng, C., Kelder, J., Verma, S., Ritchie, M., Gong, L., Klein, T., de Boer, A., Klungel, O., ten Berg, J., & Deneer, V. (2020). Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention. Genes., 11(9). https://doi.org/10.3390/genes11091068